跳至主要内容
临床试验/ISRCTN45257322
ISRCTN45257322已完成未知

Double-blind, placebo-controlled randomised trial of alpha-tocopherol and oxpentifylline in patients with radiation fibrosis

Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

  1. 2004 results in https://www.ncbi.nlm.nih.gov/pubmed/15542159 (added 25/01/2019)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Past history of early breast cancer (T1-3 N0 M0)
  • 2. No axillary surgery or lower axillary sampling only
  • 3. Radiotherapy to the breast/chest wall plus axilla and or stem cell factor (SCF)
  • 4. A minimum of 5 years post-radiotherapy
  • 5. No evidence of cancer recurrence
  • 6. Disabilities due to previous radiotherapy
  • 7. Ability to attend RMT Sutton for assessments
  • 8. Written informed consent

排除标准

  • Not provided at time of registration

研究者

发起方
Cancer Research UK (CRUK) (UK)

相似试验